These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19005685)

  • 1. Cystic fibrosis, aminoglycoside treatment and acute renal failure: the not so gentle micin.
    Bockenhauer D; Hug MJ; Kleta R
    Pediatr Nephrol; 2009 May; 24(5):925-8. PubMed ID: 19005685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimizing the toxicity of aminoglycosides in cystic fibrosis.
    Smyth AR
    J R Soc Med; 2010 Jul; 103 Suppl 1(Suppl 1):S3-5. PubMed ID: 20573667
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.
    Al-Aloul M; Miller H; Alapati S; Stockton PA; Ledson MJ; Walshaw MJ
    Pediatr Pulmonol; 2005 Jan; 39(1):15-20. PubMed ID: 15521084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES).
    Al-Aloul M; Miller H; Stockton P; Ledson MJ; Walshaw MJ
    J Cyst Fibros; 2005 Sep; 4(3):197-201. PubMed ID: 15967735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of nephrotoxicity with prolonged aminoglycoside exposure in patients with cystic fibrosis.
    Saad A; Young MR; Studtmann AE; Autry EB; Schadler A; Beckman EJ; Gardner BM; Wurth MA; Kuhn RJ
    Pediatr Pulmonol; 2020 Dec; 55(12):3384-3390. PubMed ID: 32910553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control study of acute renal failure in patients with cystic fibrosis in the UK.
    Smyth A; Lewis S; Bertenshaw C; Choonara I; McGaw J; Watson A
    Thorax; 2008 Jun; 63(6):532-5. PubMed ID: 18245146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglycoside use in cystic fibrosis: therapeutic strategies and toxicity.
    Prayle A; Smyth AR
    Curr Opin Pulm Med; 2010 Nov; 16(6):604-10. PubMed ID: 20814306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside-associated hypomagnesaemia in children with cystic fibrosis.
    Akbar A; Rees JH; Nyamugunduru G; English MW; Spencer DA; Weller PH
    Acta Paediatr; 1999 Jul; 88(7):783-5. PubMed ID: 10447142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study.
    Crowther Labiris NR; Holbrook AM; Chrystyn H; Macleod SM; Newhouse MT
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1711-6. PubMed ID: 10556145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Korean red ginseng extract on acute renal failure induced by gentamicin and pharmacokinetic changes by metformin in rats.
    Lee YK; Chin YW; Choi YH
    Food Chem Toxicol; 2013 Sep; 59():153-9. PubMed ID: 23743120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of acute renal failure in patients with cystic fibrosis in the UK.
    Bertenshaw C; Watson AR; Lewis S; Smyth A
    Thorax; 2007 Jun; 62(6):541-5. PubMed ID: 17234661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy.
    Hoffmann IM; Rubin BK; Iskandar SS; Schechter MS; Nagaraj SK; Bitzan MM
    Pediatr Pulmonol; 2002 Nov; 34(5):375-7. PubMed ID: 12357482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CR5/20--Acute renal failure in a child with cystic fibrosis awaiting lung transplantation--a good outcome after all.
    Benden C
    Paediatr Respir Rev; 2006; 7 Suppl 1():S327. PubMed ID: 17036408
    [No Abstract]   [Full Text] [Related]  

  • 15. Nebulized gentamicin in combination with systemic antibiotics for eradicating early Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Van Stormbroek B; Zampoli M; Morrow BM
    Pediatr Pulmonol; 2019 Apr; 54(4):393-398. PubMed ID: 30656856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
    Elphick HE; Scott A
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD002007. PubMed ID: 27907224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of carbenicillin in patients with cystic fibrosis.
    Boxerbaum B; Doershuk CF; Matthews LW
    J Infect Dis; 1970 Sep; 122():Suppl:S59-61. PubMed ID: 4990025
    [No Abstract]   [Full Text] [Related]  

  • 18. Nephrotoxicity in Patients with or without Cystic Fibrosis Treated with Polymyxin B Compared to Colistin.
    Crass RL; Rutter WC; Burgess DR; Martin CA; Burgess DS
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Bhatt J; Jahnke N; Smyth AR
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002009. PubMed ID: 31483853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis.
    Florescu MC; Lyden E; Murphy PJ; Florescu DF; Fillaus J
    Hemodial Int; 2012 Jul; 16(3):414-9. PubMed ID: 22469183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.